
For laboratory research use only. Not for human consumption.
Melanotan I Peptide For Sale
A synthetic research compound intended for laboratory use.
Dosage
Quantity
Bundle & Save
From
$34.99Type
Research Peptide
Category
Peptides
Batch
SHR-001
Batch number
SHR-001
Tested date
4/7/2026
What is Melanotan I?
Melanotan I (Melanotan I) is offered as a research reference material for qualified analytical and in vitro laboratory workflows. Melanotan I is manufactured for controlled laboratory environments with consistency across batches. For laboratory research use only. Not for human consumption.
How it Works
In research settings, Melanotan I is used to probe defined biological pathways under controlled laboratory conditions. Mechanistic studies typically combine receptor or cell-based assays with analytical verification of peptide identity and integrity.
Purity & Testing
99% minimum purity (per specification / COA for the active batch). Each lot is tied to batch documentation so researchers can align material received with COA and specification records before use in regulated workflows. Request a COA from this page if you need documentation prior to purchase.
Storage & Handling
Store lyophilized material per label and COA. Solvent selection and working-solution preparation must follow institutional laboratory SOPs.
Research Overview
A synthetic research compound intended for laboratory use.
Specifications
| Compound | Melanotan I |
|---|---|
| Presentation | 10mg |
| purity | High Purity |
| storage | Refrigerated (2-8C recommended) |
| type | Sterile Water |
| volume | 10mg |
| Purity | 99% |
| Catalog reference period | 56 days |
Sources & References
Peer-reviewed research
New England Journal of Medicine
Afamelanotide for Erythropoietic Protoporphyria
2015 · DOI: 10.1056/NEJMoa1411481 · PMID: 26039600
Langendonk JG, Balwani M, Anderson KE, et al.
View SourceClinical Pharmacology & Therapeutics
Afamelanotide (Nle4-D-Phe7-α-melanocyte–stimulating hormone) in dermal phototoxicity of erythropoietic protoporphyria
2010 · DOI: 10.1038/clpt.2009.302 · PMID: 20106989
Minder EI, Schneider-Yin X, Steurer J, Bachmann LM
View SourcePhotodermatology, Photoimmunology & Photomedicine
An open-label, dose–ranging study of afamelanotide for the treatment of erythropoietic protoporphyria
2014 · DOI: 10.1111/phpp.12121 · PMID: 24750391
Biolcati G, Marchesini E, Sorge F, et al.
View SourceBritish Journal of Dermatology
An open clinical study of afamelanotide in solar urticaria
2014 · DOI: 10.1111/bjd.13235 · PMID: 24910152
Haylett AK, Nie Z, Brownrigg M, et al.
View SourceExpert review of clinical pharmacology
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria
2021 · DOI: 10.1080/17512433.2021.1879638 · PMID: 33507118
Wensink D, Wagenmakers MAEM, Langendonk JG
View SourceThe New England journal of medicine
Afamelanotide for Erythropoietic Protoporphyria
2015 · DOI: 10.1056/NEJMoa1411481 · PMID: 26132941
Langendonk JG, Balwani M, Anderson KE, et al.
View SourceAmerican journal of clinical dermatology
Afamelanotide: A Review in Erythropoietic Protoporphyria
2016 · DOI: 10.1007/s40257-016-0184-6 · PMID: 26979527
Kim ES, Garnock-Jones KP
View SourceJournal of drugs in dermatology : JDD
Into the Light: Afamelanotide and the Treatment of Erythropoietic Protoporphyria in the United States
2023 · DOI: 10.36849/JDD.7126 · PMID: 37683058
Resnik SR, Targett D, Resnik BI
View SourceExpert review of clinical pharmacology
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria
2015 · DOI: 10.1586/17512433.2014.956089 · PMID: 25470471
Minder EI, Schneider-Yin X
View SourceThe Journal of dermatology
Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide
2023 · DOI: 10.1111/1346-8138.16690 · PMID: 36579412
Wensink D, Wagenmakers MAEM, Wilson JHP, et al.
View SourceFrequently Asked Questions
- What is Melanotan I used for in research?
- Melanotan I is supplied strictly as a research reference material for qualified in vitro and analytical laboratory workflows. It is not intended for human or veterinary use, diagnosis, or therapeutic application.
- How is Melanotan I purity verified?
- Batches are accompanied by specification documentation and Certificate of Analysis (COA) data where available. Review the product page and request COA details before incorporating material into regulated studies.
- How should Melanotan I be stored?
- Store lyophilized material according to the label and COA. After reconstitution, follow your institutional SOP for temperature, light exposure, and working-solution stability.
- Who can purchase Melanotan I from Science Based Peptides?
- Catalog items are sold to qualified researchers and laboratories for research use only. Buyers must confirm age and research-use eligibility before checkout.
- Does Science Based Peptides ship Melanotan I in the USA?
- Yes — we fulfill research peptide orders to qualified customers in the United States subject to product availability and our shipping policies listed at checkout.
Related Products
Request Certificate of Analysis (COA)
Need documentation for this product? Submit your name and email and we will send COA details.



